Markets

MARKETS

PE investors should hold their nerve, even if mark-to-market valuations worsen in Q2

PE investors should hold their nerve, even if mark-to-market valuations worsen in Q2

It is unlikely that the full extent of mark-to-market valuations will be known until 30 June, when Q2’s financial reports are issued. And while this might cause investors to break out into a cold sweat, the advice being offered by investment consultants is, ‘Don’t make any knee-jerk decisions and keep investing’.